Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumes.
Troussier I, Bensadoun RJ, Chamorey E, Lapeyre M, Baujat B, Leysalle A, Sun XS, Pointreau Y, Calugaru V, Pan Q, Ovidiu V, Schultz P, Malard O, Bujor L, Morinière S, Chamois J, Coutte A, Michel X, Huguet F, Fouillet B, Roth V, Vernat SS, Meert N, Gallocher O, Drouet F, Lang P, Thariat J. Troussier I, et al. Among authors: huguet f. Oral Oncol. 2014 May;50(5):e25-6. doi: 10.1016/j.oraloncology.2014.02.010. Epub 2014 Mar 11. Oral Oncol. 2014. PMID: 24630259 No abstract available.
Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
Even C, Sagaon Teyssier L, Pointreau Y, Temam S, Huguet F, Geoffrois L, Schwarzinger M; EPICORL Study Group. Even C, et al. Among authors: huguet f. PLoS One. 2021 Feb 3;16(2):e0246252. doi: 10.1371/journal.pone.0246252. eCollection 2021. PLoS One. 2021. PMID: 33534860 Free PMC article.
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.
Carsuzaa F, Lapeyre M, Gregoire V, Maingon P, Beddok A, Marcy PY, Salleron J, Coutte A, Racadot S, Pointreau Y, Graff P, Beadle B, Benezery K, Biau J, Calugaru V, Castelli J, Chua M, Di Rito A, Dore M, Ghadjar P, Huguet F, Jardel P, Johansen J, Kimple R, Krengli M, Laskar S, Mcdowell L, Nichols A, Tribius S, Valduvieco I, Hu C, Liem X, Moya-Plana A, D'onofrio I, Parvathaneni U, Takiar V, Orlandi E, Psyrri A, Shenouda G, Sher D, Steuer C, Shan Sun X, Tao Y, Thomson D, Tsai MH, Vulquin N, Gorphe P, Mehanna H, Yom SS, Bourhis J, Thariat J. Carsuzaa F, et al. Among authors: huguet f. Radiother Oncol. 2021 Jul;160:140-147. doi: 10.1016/j.radonc.2021.04.026. Epub 2021 May 11. Radiother Oncol. 2021. PMID: 33984351
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F. Meillan N, et al. Among authors: huguet f. Radiother Oncol. 2021 Aug;161:198-204. doi: 10.1016/j.radonc.2021.06.006. Epub 2021 Jun 16. Radiother Oncol. 2021. PMID: 34144078
460 results